These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1217133)

  • 1. [Histological reaction of the endometrium to intrauterine administered gestagens].
    Dallenbach-Hellweg G
    Verh Dtsch Ges Pathol; 1975; 59():566. PubMed ID: 1217133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and morphological studies in patients with a progesterone-releasing intrauterine contraceptive device (Progestasert-System) (author's transl)].
    Sievers S; Dallenbach-Hellweg G
    Geburtshilfe Frauenheilkd; 1976 Apr; 36(4):334-40. PubMed ID: 1269894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The histological reaction of the endometrium to gestagens applied locally].
    Dallenbach-Hellweg G; Sievers S
    Virchows Arch A Pathol Anat Histol; 1975 Nov; 368(4):289-98. PubMed ID: 813368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
    Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
    Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.
    Perino A; Quartararo P; Catinella E; Genova G; Cittadini E
    Acta Eur Fertil; 1987; 18(2):137-40. PubMed ID: 3115027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of progestins on human endometrium in vitro].
    Charpin C; Illouz S; Dales JP; Lavaut MN; Allasia C; Boubli L
    Bull Acad Natl Med; 2002; 186(1):125-45; discussion 145-6. PubMed ID: 12146137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
    Vereide AB; Kaino T; Sager G; Ørbo A;
    Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of emergency contraception with gestrinone: a preliminary investigation.
    Gao X; Wu E; Chen G
    Contraception; 2007 Sep; 76(3):221-7. PubMed ID: 17707720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endometrial changes in the presence of a progesterone-releasing IUD. Cytological evaluation].
    Cinel A; Insacco E; Minucci D
    Minerva Ginecol; 1988 Jan; 40(1):1-8. PubMed ID: 3287230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrauterine devices: reactions of the endometrium and alteration of the devices after varying time of exposure in situ (author's transl)].
    Ludwig H
    Verh Dtsch Ges Pathol; 1980; 64():523-35. PubMed ID: 7013339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conservative therapeutic possibilities in glandular or adenomatous endometrium hyperplasia].
    Schindler AE
    Zentralbl Gynakol; 1996; 118(6):359-64. PubMed ID: 8768014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hysterographic appearance and uterine histology at different stages of the reproductive cycle and after progestagen treatment in the domestic cat.
    Chatdarong K; Rungsipipat A; Axnér E; Linde Forsberg C
    Theriogenology; 2005 Jul; 64(1):12-29. PubMed ID: 15935839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
    Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
    Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model.
    Mönckedieck V; Sannecke C; Husen B; Kumbartski M; Kimmig R; Tötsch M; Winterhager E; Grümmer R
    Mol Hum Reprod; 2009 Oct; 15(10):633-43. PubMed ID: 19671596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal pathology of the endometrium.
    Deligdisch L
    Mod Pathol; 2000 Mar; 13(3):285-94. PubMed ID: 10757339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.